- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Stakeholder Insights on rtCGM in T2D Population Health ManagementLeading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.
Latest:
Discharge Timing and Associations With Outcomes Following Heart Failure HospitalizationA retrospective multicenter study found that patients with heart failure discharged by noon had higher short- and long-term mortality and increased early readmission rates compared with afternoon discharges.
Latest:
Predictors of and Barriers to Receipt of Advance Premium Tax CreditsFew eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.
Latest:
Medical Home Visit Programs During COVID-19 State of EmergencyThis report highlights the unique challenges faced by home health programs in addition to discussing how technology and policy changes have helped the elderly homebound during the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
Contributor: Medicare Policy Proposal Jeopardizes Care for Those on DialysisCEOs of 3 kidney care organizations explain flaws in CMS' recent reimbursement proposal.
Latest:
High-Need Beneficiary Enrollment Patterns in Medicare Advantage and Traditional MedicareAccounting for 32% of all Medicare enrollees in 2019, high-need beneficiaries were more likely to be in traditional Medicare than Medicare Advantage.
Latest:
Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and PharmacistsChanges in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.
Latest:
Balancing Efficacy, Safety, and Lifestyle in Psoriasis Therapy: Steven Daveluy, MDShared decision-making helps dermatologists align treatment plans with patient needs, improving adherence and outcomes.
Latest:
Hospital Performance in a Statewide Commercial Insurer Episode-Based Incentive ProgramSome hospitals were able to outperform others in a commercial insurer episode-based incentive program, but there was little evidence of global reductions in episode spending.
Latest:
Bleeds and Resource Use in Hemophilia B: Retrospective Observational StudyThis real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.
Latest:
Provider Shortages, Coverage, Cost Are Top Barriers to Care: CHEST 2025 ExpertsExperts at CHEST 2025 highlight rising costs, insurance complexity, and workforce shortages as major barriers to health care access in the US.
Latest:
Contributor: In the Misdiagnosis of Menopause, What Needs to Change?Menopause symptoms are not being recognized, leading to misdiagnosis and improper treatment.
Latest:
COPD Treatment Ratio: A Measure for Improving COPD Population HealthThis article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.
Latest:
Final Thoughts on Arrhythmia ManagementExperts agree that developing value-based care models for atrial fibrillation requires collaborative, data-driven strategies—leveraging clinical pharmacists for personalized medication management and prioritizing stroke prevention and rhythm control—while embracing innovation and workforce redesign to balance quality, cost-effectiveness, and avoid overdiagnosis in an evolving health care landscape.
Latest:
Teamwork Enhances Patient Experience: Linking TEAM and Net Promoter ScoresIn 1386 providers, better teamwork related to higher patient Net Promoter Score (NPS), and the relationship between provider experience and NPS was mediated by teamwork.
Latest:
Switching to Biosimilars for the Management of PsoriasisAn expert discusses how examining biosimilars in trials ensures safety, efficacy, and interchangeability, key for clinical adoption. The phase 3 study’s week 52 results confirmed consistent pharmacokinetics, efficacy, and safety. As confidence grows, biosimilars will expand treatment access for psoriasis patients.
Latest:
Breaking Barriers, Fostering Collaboration at AACR Annual Meeting 2025Program chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD, highlight the cross-disciplinary approach to cancer research and innovation being taken at this year's American Association for Cancer Research (AACR) Annual Meeting.
Latest:
Hospital Participation in Medicare ACOs: No Change in Admission Practices and SpendingHospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Latest:
Access to Consultative Dermatologic Care via Physician-to-Physician Asynchronous Outpatient TeledermatologyDirect access of primary care physicians to dermatologists via asynchronous teledermatology improves a health system’s ability to increase patient access to dermatologic care.
Latest:
AI Is Not Going to Replace Doctors, It’s Going to Empower Them: Dr Mehmet OzDuring a visit to AtlantiCare, CMS Administrator Mehmet Oz, MD, MBA, called for rural health systems to modernize IT infrastructure through the $50 billion Rural Transformation Fund, including through artificial intelligence (AI).
Latest:
FIBRONEER Trials Show Nerandomilast's Promise as New Treatment Option for IPF/PPF: Toby Maher, MD, PhDToby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC, shares trial findings from the FIBRONEER-IPF (NCT05321069) and FIBRONEER-ILD (NCT05321082) studies on nerandomilast.
Latest:
Effective Implementation of Collaborative Care for Depression: What Is Needed?Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.
Latest:
A Standardized Care Pathway Increases Optimal Dialysis StartsThe authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.
Latest:
Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 YearsThis paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.
Latest:
Health Care Affordability Goes Beyond Just Drug Prices: H. John Beardsley and Fauzea HussainSystemic barriers beyond just the price of drugs can impact health care costs, emphasizing the need for comprehensive affordability solutions, explained H. John Beardsley, MBA, of CoverMyMeds, and Fauzea Hussain, MPH, of McKesson.
Latest:
Journey to Anticoagulant Access Following Payer Rejection of ApixabanFormulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.
Latest:
Costs for Commercially Insured Adults Prescribed Second-line Diabetes MedicationsAdults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
